ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1002

Proximal Tubule Angiotensin II Type 1 Receptor-Associated Protein Does Not Influence Angiotensin-Dependent Hypertension

Session Information

Category: Hypertension and CVD

  • 1403 Hypertension and CVD: Mechanisms

Authors

  • Wakui, Hiromichi, Yokohama City University, Kanagawa, Yokohama city, Japan
  • Kinguchi, Sho, Yokohama City University, Kanagawa, Yokohama city, Japan
  • Yamaji, Takahiro, Yokohama city unversity, Yokohama City, Japan
  • Uneda, Kazushi, Yokohama City University, Kanagawa, Yokohama city, Japan
  • Urate, Shingo, Yokohama City University Graduate School of Medicine, Kanazawa-Ku, KANAGAWA, Japan
  • Haruhara, Kotaro, The Jikei University School of Medcine, Tokyo, Japan
  • Ohki, Kohji, Yokohama City University School of Medicine, Yokohama City, Japan
  • Kobayashi, Ryu, Yokohama City University Graduate School of Medicine, Kanazawa-Ku, KANAGAWA, Japan
  • Azushima, Kengo, Yokohama City University, Kanagawa, Yokohama city, Japan
  • Toya, Yoshiyuki, Yokohama City University, Kanagawa, Yokohama city, Japan
  • Tamura, Kouichi, Yokohama City University Graduate School of Medicine, Kanazawa-Ku, KANAGAWA, Japan
Background


The activation of renal angiotensin II (Ang II) type 1 receptor (AT1R) can evoke excessive sodium retention, resulting in hypertension when inappropriately stimulated. The AT1R-associated protein (ATRAP) has been identified as the specific binding protein of the C-terminal domain of AT1R, and functions as an endogenous inhibitor that suppresses AT1R hyper-activation at local tissue sites. We previously reported that systemic ATRAP-knockout mice (ATRAP-KO) exhibited an exacerbation of Ang II-induced hypertension, concomitant with an increase in sodium retention, compared wild-type mice (WT). We here report a functional role of proximal tubule ATRAP in angiotensin-dependent hypertension using proximal tubule-specific ATRAP-knockout (PT-KO) mice.

Methods

In the present study, we generated PT-KO mice for the first time by the Cre/loxP system using Pepck-Cre. We next compared blood pressure in response to Ang II (1000ng/kg/min) treatment in wild-type littermate control (LC) and PT-KO mice. Since cardiac hypertrophy is closely associated with the blood pressure elevation, we further examined heart weight/body weight ratio in PT-KO and LC mice.

Results


The ATRAP mRNA expression in the proximal tubules of the PT-KO mice was decreased by approximately 80% compared with LC mice, estimated by laser capture microdissection method. Ang II infusion for 2 weeks significantly and similarly increased systolic blood pressure in both PT-KO and LC mice. Ang II infusion for 2 weeks significantly increased heart weight/body weight ratio in both PT-KO and LC mice to the same extent.

Conclusion

These results indicate that ATRAP deficiency in proximal nephron does not influence angiotensin-dependent hypertension in vivo.